- Report
- May 2026
- 180 Pages
Global
From €4029EUR$4,500USD£3,459GBP
- Report
- January 2026
- 186 Pages
Global
From €3174EUR$3,545USD£2,725GBP
€3526EUR$3,939USD£3,027GBP
- Report
- August 2026
- 377 Pages
Global
From €5237EUR$5,850USD£4,496GBP
- Report
- June 2026
- 199 Pages
Global
From €3174EUR$3,545USD£2,725GBP
€3526EUR$3,939USD£3,027GBP
- Report
- February 2026
- 250 Pages
Global
From €4020EUR$4,490USD£3,451GBP
- Report
- February 2026
- 250 Pages
Global
From €4020EUR$4,490USD£3,451GBP
- Report
- February 2026
- 250 Pages
Global
From €4020EUR$4,490USD£3,451GBP
- Report
- February 2026
- 250 Pages
Global
From €4020EUR$4,490USD£3,451GBP
- Report
- February 2026
- 250 Pages
Global
From €4020EUR$4,490USD£3,451GBP
- Report
- February 2026
- 250 Pages
Global
From €4020EUR$4,490USD£3,451GBP
- Report
- August 2026
- 93 Pages
Global
From €5013EUR$5,600USD£4,304GBP
- Report
- August 2026
- 382 Pages
Global
From €5237EUR$5,850USD£4,496GBP
- Report
- August 2026
- 506 Pages
Global
From €5237EUR$5,850USD£4,496GBP
- Report
- May 2026
- 185 Pages
Global
From €4029EUR$4,500USD£3,459GBP
- Report
- January 2026
- 185 Pages
Global
From €4029EUR$4,500USD£3,459GBP
- Drug Pipelines
- May 2026
- 80 Pages
Global
From €1790EUR$2,000USD£1,537GBP
- Report
- May 2026
- 100 Pages
Global
From €2416EUR$2,699USD£2,074GBP
- Report
- May 2026
- 150 Pages
Global
From €2497EUR$2,789USD£2,144GBP
- Report
- May 2026
- 350 Pages
Global
From €4430EUR$4,949USD£3,804GBP
- Report
- May 2026
- 350 Pages
Global
From €4430EUR$4,949USD£3,804GBP

Levodopa is a drug used to treat Parkinson's disease, a neurological disorder that affects movement. It is a dopamine precursor, meaning it is converted into dopamine in the brain, which helps to reduce the symptoms of Parkinson's. Levodopa is usually taken in combination with other drugs, such as carbidopa, to increase its effectiveness. It is one of the most commonly prescribed drugs for Parkinson's, and is often the first line of treatment.
Levodopa is a part of the larger Central Nervous System (CNS) drug market, which includes drugs used to treat a variety of neurological disorders. The CNS drug market is highly competitive, with many different companies offering various treatments.
Some of the companies in the Levodopa market include Merck, Novartis, Teva Pharmaceuticals, and Sun Pharmaceuticals. Show Less Read more